Skip to main content
. Author manuscript; available in PMC: 2019 Jul 29.
Published in final edited form as: Dev Psychopathol. 2018 Aug;30(3):773–785. doi: 10.1017/S0954579418000639

Figure 1.

Figure 1.

Maternal medication use during pregnancy. These classifications were based on maternal medication use at all three assessments (at 24 ± 2, 30 ± 2, and 36 ± 2 weeks gestation). The majority of women (n = 117; 73%) did not change their medication status over pregnancy, described above as “consistently” within that category. Thirty women (19%) had only one medication assessment; their medication group membership was determined based on the medication information available. A minority of women (n = 14; 9%) changed medication groups over time (e.g., 6 women began the study not taking medication but added an SRI only). These women were categorized as delineated above. Maternal medication use was treated as time varying in the models (so group membership changes were accounted for in the models); this figure is meant to give a general sense of the types of medication use (and combinations of medication) reported in this sample over the course of the study.